Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study-Reference-Cited by-同舟云学术

Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study

Published:2014-10-12 Issue:2 Volume:49 Page:404-414
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Chou Yu-Ching,Kuan Jen-Chun,Bai Chyi-Huey,Yang Tsan,Chou Wan-Yun,Hsieh Po-Chien,You San-Lin,Hwang Lee-Ching,Chen Chien-Hua,Wei Cheng-Yu,Sun Chien-An

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-014-0447-z.pdf

Reference47 articles.

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)

2. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, W.M. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cifkova, C. Deaton, S. Ebrahim, M. Fisher, G. Germano, R. Hobbs, A. Hoes, S. Karadeniz, A. Mezzani, E. Prescott, L. Ryden, M. Scherer, M. Swanne, W.J. Op Reimer, C. Vrints, D. Wood, J.L. Zamorano, F. Zannad, European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European guidelines on cardiovascular disease prevention in clinical practice. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33, 1635–1701 (2012)

3. S.M. Grundy, Low-density lipoprotein, non-high-density lipoprotein and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106, 2526–2529 (2002)

4. J. Genest, J. Frohlich, G. Fodor, R. McPherson, Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Can. Med. Assoc. J. 169, 921–924 (2003)

5. O. Faergeman, Introduction: apolipoproteins and guidelines for prevention of cardiovascular disease. J. Intern. Med. 259, 434–436 (2006)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis;Lipids in Health and Disease;2023-07-07

2. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome;Frontiers in Endocrinology;2022-01-05

3. Biomarkers in metabolic syndrome;Advances in Clinical Chemistry;2022

4. Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review;Obesity Reviews;2021-07-13

5. Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan;Diagnostics;2020-07-23